Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 6,457-6,468 of 10,612

Drug study icon

TerminatedNCT03395314

Ketamine in Borderline Personality Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityDrugFrom 21 Years to 60 Years

Countries: United States
Sponsor: Yale University
Condition: Suicidality

Drug study icon

CompletedNCT01700829

Ketamine in the Treatment of Suicidal Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SuicidalityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Depression, Suicidality

Drug study icon

CompletedNCT02579928

Ketamine Infusion for Adolescent Depression and Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, AnxietyDrugFrom 13 Years to 17 Years

Countries: United States
Sponsor: Yale University
Condition: Depression, Anxiety

Drug study icon

CompletedNCT04322968

Ketamine Infusion for Comorbid PTSD and Chronic Pain

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: VA Ann Arbor Healthcare System
Condition: PTSD

Drug study icon

CompletedNCT01349231

Ketamine Infusion for OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: OCD

Drug study icon

CompletedNCT01582945

Ketamine Infusion for Treatment-resistant Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Depression

Drug study icon

CompletedNCT03088384

Ketamine Infusion Therapy for PTSD in Combat Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Klarisana Physician Services PLLC
Condition: PTSD

Drug study icon

CompletedNCT03947099

Ketamine Infusion Therapy for PTSD in Paramedics

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AnxietyDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Klarisana Physician Services PLLC
Condition: PTSD, Anxiety

Drug study icon

CompletedNCT02577250

Ketamine Infusions for PTSD and Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, PTSDDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Minneapolis Veterans Affairs Medical Center
Condition: Depression, PTSD

Drug study icon

SuspendedNCT06767566

Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugOver 18 Years

Countries: United States
Sponsor: University of Utah
Condition: Depression

Drug study icon

CompletedNCT04037085

Ketamine to Improve Recovery After Cesarean Delivery - Part 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 99 Years

Countries: United States
Sponsor: Grace Lim, MD, MS
Condition: Depression

Drug study icon

CompletedNCT02422290

Ketamine Treatment for Pediatric-Refractory OCD (OCD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 14 Years to 22 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: OCD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.